Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2026)

Guardian Pharmacy Services has reported Cash from Investing Activities for 4 years, with the latest figure at -$4.8 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 14.34% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.4 million (up 2.86% YoY) and the FY2025 annual result came in at -$32.2 million, down 5.98% from the prior year.
• Cash from Investing Activities retreated to -$4.8 million in Q1 2026 per GRDN's latest filing, from -$4.7 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$1.1 million in Q4 2023 and troughed at -$13.1 million in Q2 2024.
• A 4-year average of -$6.9 million and a median of -$6.1 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities tumbled 477.51% in 2024, then gained 28.89% in 2025.
• Over 4 years, Cash from Investing Activities stood at -$1.1 million in 2023, then sank by 477.51% to -$6.6 million in 2024, then increased by 28.89% to -$4.7 million in 2025, then declined by 0.85% to -$4.8 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$4.8 million, -$4.7 million, and -$9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.